We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

204 hedge funds and large institutions have $1.1B invested in Sage Therapeutics in 2024 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 70 increasing their positions, 61 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more call options, than puts

Call options by funds: $5.76M | Put options by funds: $3.67M

17% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 24

15% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 61

2.38% more ownership

Funds ownership: 94.92% → 97.3% (+2.4%)

2% more funds holding

Funds holding: 200 → 204 (+4)

11% less capital invested

Capital invested by funds: $1.23B → $1.1B (-$138M)

Holders
204
Holders Change
+4
Holders Change %
+2%
% of All Funds
2.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
70
Reduced
61
Closed
24
Calls
$5.76M
Puts
$3.67M
Net Calls
+$2.09M
Net Calls Change
-$5.32M

Top Buyers

Rank Fund Capital Flow
1
BG
Bellevue Group
Switzerland
+$22M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$14.8M
3
State Street
State Street
Massachusetts
+$13.3M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$9.96M
5
BBA
Baker Bros. Advisors
New York
+$9.39M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$30.2M
2
CAC
Cowen and Company
New York
-$20.9M
3
JP Morgan Chase
JP Morgan Chase
New York
-$11.9M
4
Morgan Stanley
Morgan Stanley
New York
-$11.2M
5
Citadel Advisors
Citadel Advisors
Florida
-$6.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
PS
201
Principal Securities
Iowa
$112 -$1.04K -45 -88%
DPW
202
DiNuzzo Private Wealth
Pennsylvania
$94 – – –
FHA
203
First Horizon Advisors
Tennessee
$19 – – –
DCM
204
DAFNA Capital Management
California
– -$5.31M -245,000 Closed
SC
205
Stempoint Capital
New York
– -$4.73M -218,319 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
206
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$4.36M -201,107 Closed
Primecap Management
207
Primecap Management
California
– -$1.62M -74,950 Closed
AQR Capital Management
208
AQR Capital Management
Connecticut
– -$1.45M -67,042 Closed
HF
209
HRT Financial
New York
– -$1.44M -66,244 Closed
BCM
210
Bayesian Capital Management
New York
– -$898K -41,425 Closed
LCM
211
Landscape Capital Management
New Jersey
– -$765K -35,301 Closed
EAM
212
Exome Asset Management
New York
– -$764K -35,257 Closed
TRSOTSOK
213
Teachers Retirement System of the State of Kentucky
Kentucky
– -$456K -21,020 Closed
SSA
214
Schonfeld Strategic Advisors
New York
– -$455K -20,992 Closed
FRM
215
Fox Run Management
Connecticut
– -$272K -12,556 Closed
OA
216
Oracle Alpha
Ontario, Canada
– -$222K -10,237 Closed
Walleye Trading
217
Walleye Trading
New York
– -$164K -7,561 Closed
SO
218
STRS Ohio
Ohio
– -$158K -7,300 Closed
EC
219
EntryPoint Capital
New York
– -$153K -7,066 Closed
BCV
220
Banque Cantonale Vaudoise
Switzerland
– -$23K -1,042 Closed
Federated Hermes
221
Federated Hermes
Pennsylvania
– -$11.6K -534 Closed
WIM
222
Westside Investment Management
California
– -$6.5K -300 Closed
ODG
223
O'Dell Group
Ohio
– -$4.33K -200 Closed
FWM
224
Focused Wealth Management
New York
– -$2.17K -100 Closed
GWS
225
Glassman Wealth Services
Virginia
– -$303 -14 Closed
6 7 8
9
10

SAGE Hedge Fund Activity: Q1 2024 in Review

204 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q1 2024, worth a combined $1.1B — down 11% from $1.23B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new SAGE positions and 24 closed out — a net gain of 4 holders — while 70 added to existing stakes and 61 trimmed.

The largest buyer was Bellevue Group, adding an estimated $22M. The largest seller was Wellington Management Group, cutting an estimated $30.2M.

  • 204 institutional investors held Sage Therapeutics (SAGE) as of Q1 2024, up from 200 in Q4 2023.
  • Funds reported $1.1B of Sage Therapeutics stock for Q1 2024, down 11% quarter-over-quarter.
  • 28 funds opened new Sage Therapeutics positions in Q1 2024 and 24 closed out, a net change of +4 holders.
  • The largest Sage Therapeutics buyer in Q1 2024 was Bellevue Group, an estimated $22M added.
  • The largest Sage Therapeutics seller in Q1 2024 was Wellington Management Group, an estimated $30.2M sold.

Based on aggregated 13F filings for Q1 2024.